Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)
Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473